Mindset Pharma Identifies New Pharmacological Insights of First Generation Psychedelics Through...

Awakn Files Patent For A New Class Of Entactogen-Like Molecules

Entheon Biomedical Partners with Wavepaths on Upcoming Observational Study

PharmaTher Announces Grant of U.S. Patent on Ketamine Formulation

Nova Mentis Study Confirms Oral Microdose Psilocybin Treatment of Autism

Mydecine Announces MYCO-005 Family of Improved Safety Microdose Novel Molecules

atai Impact Donates to the Multidisciplinary Association for Psychedelic Studies (MAPS)...

BetterLife Lead Drug (BETR-001) Promotes Structural Neural Plasticity in Preclinical Model

Psyched Wellness Announces Key Findings from the 90-Day Oral Toxicity Study...

PT293 – Stanislav & Brigitte Grof – The Evolution of Breathwork...

Load more